ASPN Stock: Price, Forecast, Financials & AI Analysis

High

Open

VWAP

Vol

Mkt Cap

Low

Amount

EV/EBITDA(TTM)

Total Shares

EV/OCF(TTM)

P/S(TTM)

Market Estimates

Earnings Estimates

Revenue

YoY Chg

EPS

YoYChg

FY2025Q4

FY2026Q1

FY2026Q2

44.42M

-63.91%

-0.215

-253.43%

49.10M

-37.62%

-0.145

+142.08%

53.84M

-31%

-0.095

+137.5%

Estimates Revision

The market is revising Downward the revenue expectations for Aspen Aerogels, Inc. (ASPN) for FY2025, with the revenue forecasts being adjusted by -9.65% over the past three months. During the same period, the stock price has changed by -52.31%.

Revenue Estimates for FY2025

Revise Downward

-9.65%

In Past 3 Month

EPS Estimates for FY2025

Revise Downward

-6.56%

In Past 3 Month

Stock Price

Go Down

-52.31%

In Past 3 Month

5 Analyst Rating

Wall Street analysts forecast ASPN stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for ASPN is 5.00 USD with a low forecast of 4.00 USD and a high forecast of 6.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

3 Buy

1 Hold

1 Sell

Moderate Buy

Current: 3.200

Low

4.00

Averages

5.00

High

6.00

Current: 3.200

Low

4.00

Averages

5.00

High

6.00

Barclays

Underweight

downgrade

$6 -> $4

2025-11-07

Reason

Barclays

Price Target

$6 -> $4

2025-11-07

downgrade

Underweight

Reason

Barclays lowered the firm's price target on Aspen Aerogels to $4 from $6 and keeps an Underweight rating on the shares. The company reported a "tough" quarter with a substantial guide-down to full year numbers following General Motors' decision to cut production of electric vehicles, the analyst tells investors in a research note.

Canaccord

George Gianarikas

Buy

downgrade

$10 -> $5

2025-11-07

Reason

Canaccord

George Gianarikas

Price Target

$10 -> $5

2025-11-07

downgrade

Buy

Reason

Canaccord analyst George Gianarikas lowered the firm's price target on Aspen Aerogels to $5 from $10 and keeps a Buy rating on the shares. The firm said with a solid balance sheet and minimal capital expenditure needs, liquidity is expected to remain healthy. And looking past 2026, they expect a return to healthy levels of EBITDA with material flow through to free cash flow.

Barclays

Equal Weight -> Underweight

downgrade

$7 -> $6

2025-08-11

Reason

Barclays

Price Target

$7 -> $6

2025-08-11

downgrade

Equal Weight -> Underweight

Reason

Barclays downgraded Aspen Aerogels (ASPN) to Underweight from Equal Weight with a price target of $6, down from $7. With the the removal of the $7,500 electric vehicle tax credit to consumers, the firm expects General Motors (GM) to cut EV production and produce only 150,000 vehicles in 2027. It sees "inescapable macroeconomic forces" putting downward pressure on Aspen's fastest-growing business, its Thermal Barrier segment. Barclays cites Aspen's reliance on GM and the sensitivity of Thermal Barrier gross margins to production volumes for the downgrade.

Canaccord

Buy

downgrade

$11 -> $10

2025-08-08

Reason

Canaccord

Price Target

$11 -> $10

2025-08-08

downgrade

Buy

Reason

Canaccord lowered the firm's price target on Aspen Aerogels to $10 from $11 and keeps a Buy rating on the shares. The firm noted they reported a Q2 beat but with a downside to profitability. They believe management is taking the right steps to rightsize the business preserving marginal profitability with a cost structure that reflects the current reality. Limited capex should help the company maintain relative free cash flow neutrality in a new normal. With net cash on the balance sheet, Aspen also has the cash on hand to help weather the storm.

Barclays

Overweight -> Equal Weight

downgrade

$13 -> $7

2025-05-29

Reason

Barclays

Price Target

$13 -> $7

2025-05-29

downgrade

Overweight -> Equal Weight

Reason

B. Riley

Buy

downgrade

$22 -> $10

2025-05-09

Reason

B. Riley

Price Target

$22 -> $10

2025-05-09

downgrade

Buy

Reason

B. Riley lowered the firm's price target on Aspen Aerogels to $10 from $22 and keeps a Buy rating on the shares following the Q1 report. The firm cut estimates, noting Aspen guided below expectations. The company is educing fixed costs, with a line of sight to meaningful growth in 2027, the analyst tells investors in a research note.

Valuation Metrics

The current forward P/E ratio for Aspen Aerogels Inc (ASPN.N) is -6.45, compared to its 5-year average forward P/E of 14.43. For a more detailed relative valuation and DCF analysis to assess Aspen Aerogels Inc 's fair value, click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.

N/A

5Y Average PE

14.43

Current PE

-6.45

Overvalued PE

73.86

Undervalued PE

-44.99

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.

N/A

5Y Average EV/EBITDA

-14.92

Current EV/EBITDA

-45.10

Overvalued EV/EBITDA

25.79

Undervalued EV/EBITDA

-55.64

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.

5Y Average PS

3.93

Current PS

1.28

Overvalued PS

6.85

Undervalued PS

1.01

Financials

Annual

Quarterly

N/A

Total Revenue

N/A

Operating Profit

N/A

Net Income after Tax

N/A

EPS - Diluted

N/A

Free Cash Flow

N/A

Gross Profit Margin - %

N/A

FCF Margin - %

N/A

Net Margin - %

N/A

ROIC

Trading Trends

Insider

Insiders areSelling! The selling amount has increased 288.04% over the last month.

Sold

Bought

Hedge Fund

Hedge Funds are Neutral. There are no significant trading trends over the last quarter.

Sold

Bought

Congress Trading

Congress are Neutral. There are no significant trading trends over the last month.

Sold

Bought

Insider

Insiders areSelling! The selling amount has increased 288.04% over the last month.

Sold

Bought

ASPN News & Events

Events Timeline

No data

News

4.0

11-14NASDAQ.COM

Daily Upgrade Report for Validea's Joseph Piotroski Strategy - November 14, 2025

4.0

11-07Benzinga

Canaccord Genuity Keeps Buy Rating on Aspen Aerogels, Reduces Price Target to $5

9.5

11-07NASDAQ.COM

Key Metrics Reveal Insights on Aspen Aerogels (ASPN) Q3 Earnings

People Also Watch

Frequently Asked Questions

What is Aspen Aerogels Inc (ASPN) stock price today?

The current price of ASPN is 3.2 USD — it has decreased -0.62 % in the last trading day.

What is Aspen Aerogels Inc (ASPN)'s business?

Aspen Aerogels, Inc. is an aerogel technology company, which provides sustainability and electrification solutions. Its aerogel technology enables its customers and partners to achieve their own objectives around the global megatrends of resource efficiency, e-mobility and clean energy. Its segments include Energy Industrial and Thermal Barrier. Under the Energy Industrial, it designs, develops and manufactures aerogel insulation used in the energy industrial and sustainable insulation markets. It offers two aerogel insulation product lines for the energy industrial market, Pyrogel and Cryogel. Under the Thermal Barrier, it offers PyroThin product, is an ultra-thin, lightweight and flexible thermal barrier designed with other functional layers to impede the propagation of thermal runaway across multiple lithium-ion battery system architectures. Its thermal barrier technology is designed to offer a combination of thermal management, mechanical performance and fire protection properties.

What is the price predicton of ASPN Stock?

What is Aspen Aerogels Inc (ASPN)'s revenue for the last quarter?

Aspen Aerogels Inc revenue for the last quarter amounts to 73.02M USD, decreased -37.77 % YoY.

What is Aspen Aerogels Inc (ASPN)'s earnings per share (EPS) for the last quarter?

Aspen Aerogels Inc. EPS for the last quarter amounts to -0.08 USD, decreased -52.94 % YoY.

What changes have occurred in the market's expectations for Aspen Aerogels Inc (ASPN)'s fundamentals?

How many employees does Aspen Aerogels Inc (ASPN). have?

Aspen Aerogels Inc (ASPN) has 554 emplpoyees as of December 15 2025.

What is Aspen Aerogels Inc (ASPN) market cap?

Today ASPN has the market capitalization of 266.12M USD.